Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Abbott Laboratories    ABT

ABBOTT LABORATORIES

(ABT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 2017 2018 2019 2020 (e) 2021 (e) 2022 (e)
Sales 27 390 30 578 31 904 31 283 35 441 38 089
EBITDA 7 022 9 833 8 188 7 456 9 193 9 828
Operating profit (EBIT) 5 976 6 555 7 110 6 432 8 015 8 945
Pre-Tax Profit (EBT) 2 231 2 873 4 077 4 848 - -
Net income 353 2 334 3 687 2 738 5 058 6 352
P/E ratio 285x 55,2x 42,2x 61,3x 30,3x 24,2x
EPS ( $ ) 0,20 1,31 2,06 1,40 2,84 3,56
Dividend per Share ( $ ) 1,08 1,16 1,32 1,42 1,54 1,71
Yield 1,88% 1,60% 1,52% 1,65% 1,79% 1,99%
Reference price ( $ ) 57,070 72,330 86,860 86,040 86,040 86,040
Announcement Date 01/24/2018
12:45pm
01/23/2019
12:45pm
01/22/2020
12:30pm
- - -
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 2017 2018 2019 2020 (e) 2021 (e) 2022 (e)
Debt 18 314 15 480 13 999 10 983 6 881 7 209
Finance - - - - - -
Operating income (EBITDA) 7 022 9 833 8 188 7 456 9 193 9 828
Leverage
(Debt/EBITDA)
2,61x 1,57x 1,71x 1,47x 0,75x 0,73x
Capital Expenditure 1 000 1 394 1 638 1 650 1 770 1 812
Free Cash Flow (FCF) 4 435 4 906 4 498 5 589 6 594 7 034
Book Value Per Share (BVPS) ( $ ) 17,7 17,4 17,6 23,2 24,7 16,9
Cash Flow per Share ( $ ) 3,18 3,56 3,45 3,88 3,85 -
Announcement Date 01/24/2018
12:45pm
01/23/2019
12:45pm
01/22/2020
12:30pm
- - -
Balance Sheet Analysis
Financial data source
© 2020 S&P Global Market Intelligence
Financial Ratios

Size 2020e 2021e
Capitalization 151 726 M $ -
Entreprise Value (EV) 162 709 M $ 158 607 M $
Valuation 2020e 2021e
P/E ratio (Price / EPS) 61,3x 30,3x
Capitalization / Revenue 4,85x 4,28x
EV / Revenue 5,20x 4,59x
EV / EBITDA 21,8x 17,7x
Yield (DPS / Price) 1,65% 1,79%
Price to book (Price / BVPS) 3,71x 3,48x
Profitability 2020e 2021e
Operating Margin (EBIT / Sales) 20,6% 22,6%
Operating Leverage (Delta EBIT / Delta Sales) -4,90x 1,85x
Net Margin (Net Profit / Revenue) 8,75% 14,3%
ROA (Net Profit / Asset) 6,99% 9,51%
ROE (Net Profit / Equities) 14,6% 16,8%
Rate of Dividend 101% 54,3%
Balance Sheet Analysis 2020e 2021e
CAPEX / Sales   5,27% 4,99%
Cash Flow / Sales 21,9% 19,1%
Capital Intensity (Assets / Sales) 1,25x 1,50x
Financial Leverage (Net Debt / EBITDA) 1,47x 0,75x
EPS & Dividend